JavaScript is disabled for your browser. Some features of this site may not work without it.
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy
Başlık:First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy; in patients with metastatic colorectal cancer: Onco-colon Turkey study; subgroup analysis